Table 1 Characteristic of subjects with AEFI (n = 388)
Characteristics | Bleeding (n = 55) | No Bleeding (n = 333) | |||
|---|---|---|---|---|---|
Age | 0-1 year | 45 | (81.8%) | 313 | (94.0%) |
1–2 year | 6 | (10.9%) | 15 | (4.5%) | |
> 2 year | 4 | (7.3%) | 5 | (1.5%) | |
Gender | Male | 44 | (80.0%) | 196 | (58.9%) |
Female | 11 | (20.0%) | 137 | (41.1%) | |
Vaccination | Hep B0 | 22 | (40.0%) | 68 | (20.4%) |
BCG | 12 | (21.8%) | 25 | (7.5%) | |
Polio | 0 | 0 | 14 | (4.2%) | |
DTP | 3 | (5.4%) | 36 | (10.8%) | |
DTP-HB | 4 | (7.3%) | 91 | (27.4%) | |
DTP-HB-Hib | 9 | (16.4%) | 72 | (21.6%) | |
Measles | 4 | (7.3%) | 22 | (6.6%) | |
Td | 1 | (1.8%) | 5 | (1.5%) | |
AEFI classification | Vaccine reaction | 0 | 0 | 149 | (44.8%) |
Program error | 4 | (7.3%) | 45 | (13.5%) | |
Coincidence | 41 | (74.5%) | 56 | (16.8%) | |
Injection reaction | 0 | 0 | 58 | (17.4%) | |
Unknown | 10 | (18.2%) | 25 | (7.5%) | |
Outcomes | Recovered | 37 | (67.3%) | 298 | (89.5%) |
Sequelae | 2 | (3.6%) | 12 | (3.6%) | |
Died | 16 | (29.1%) | 23 | (6.9%) | |